Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline
| dc.contributor.author | Ye Z | |
| dc.contributor.author | Rochwerg B | |
| dc.contributor.author | Wang Y | |
| dc.contributor.author | Adhikari NK | |
| dc.contributor.author | Murthy S | |
| dc.contributor.author | Lamontagne F | |
| dc.contributor.author | Fowler RA | |
| dc.contributor.author | Qiu H | |
| dc.contributor.author | Wei L | |
| dc.contributor.author | Sang L | |
| dc.contributor.author | Loeb M | |
| dc.contributor.author | Shen N | |
| dc.contributor.author | Huang M | |
| dc.contributor.author | Jiang Z | |
| dc.contributor.author | Arabi YM | |
| dc.contributor.author | Colunga-Lozano LE | |
| dc.contributor.author | Jiang L | |
| dc.contributor.author | Koh Y | |
| dc.contributor.author | Liu D | |
| dc.contributor.author | Liu F | |
| dc.contributor.author | Phua J | |
| dc.contributor.author | Shen A | |
| dc.contributor.author | Huo T | |
| dc.contributor.author | Du B | |
| dc.contributor.author | Zhai S | |
| dc.contributor.author | Guyatt GH | |
| dc.date.accessioned | 2021-06-07T15:46:34Z | |
| dc.date.available | 2021-06-07T15:46:34Z | |
| dc.date.issued | 2020-05-19 | |
| dc.date.updated | 2021-06-07T15:46:34Z | |
| dc.identifier.doi | https://doi.org/10.1503/cmaj.200648 | |
| dc.identifier.issn | 0820-3946 | |
| dc.identifier.issn | 1488-2329 | |
| dc.identifier.uri | http://hdl.handle.net/11375/26514 | |
| dc.publisher | CMA Joule Inc. | |
| dc.rights | Attribution-NonCommercial-NoDerivs - CC BY-NC-ND This license is the most restrictive of the main Creative Commons licenses, only allowing others to download your works and share them with others as long as they credit you, but they can?t change them in any way or use them commercially. | |
| dc.rights.license | Attribution-NonCommercial-NoDerivs - CC BY-NC-ND | |
| dc.rights.uri | 7 | |
| dc.subject | Adrenal Cortex Hormones | |
| dc.subject | Antiviral Agents | |
| dc.subject | COVID-19 | |
| dc.subject | Coronavirus Infections | |
| dc.subject | Evidence-Based Medicine | |
| dc.subject | Humans | |
| dc.subject | Pandemics | |
| dc.subject | Plasma | |
| dc.subject | Pneumonia, Viral | |
| dc.subject | Practice Guidelines as Topic | |
| dc.subject | Severity of Illness Index | |
| dc.title | Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- E536.full.pdf
- Size:
- 103.97 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version